|Articles|December 1, 2018
- Pharmaceutical Executive-12-01-2018
- Volume 38
- Issue 12
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Science & Finance: The Biotech Blendover 7 years ago
Europe’s Digital Health Path Still at a Crossroadsover 7 years ago
Lessons for Pharma from the Merck Cyber Attackover 7 years ago
Securing a Winning Strategy for Real-World Evidenceover 7 years ago
RWE: Answering Questions in Rare Diseaseover 7 years ago
Measuring the Probability of Pricing and Access Successover 7 years ago
Four Challenges for AI in the Life Sciencesover 7 years ago
Country Report: MalaysiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Pharmaceutical Executive Daily: FDA Approves Breztri
3
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
4
How are US Regulatory Actions Impacting Pricing?
5